Financials
- Market Capitalization 179.11 M
- Employee 187
- Founded 2012
- CEO Daniel A. de Boer
- Website www.proqr.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3689 | EQ Equillium, Inc. - Common Stock | 2.88 USD | -1.03% | +3.23% | -0.35% | +747.06% | 182.09 M USD | ||
| 3695 | ADAG Adagene Inc - ADS, each representing 1.25 | 3.82 USD | -3.05% | -2.05% | +5.52% | +98.96% | 181.01 M USD | ||
| 3704 | CRBU Caribou Biosciences, Inc. - Common Stock | 1.80 USD | -6.74% | -2.70% | +10.43% | +4.65% | 178.53 M USD | ||
| 3732 | PEPG PepGen Inc. - Common Stock | 2.44 USD | +4.27% | +28.42% | +63.76% | +89.15% | 168.77 M USD |
Frequently asked questions about ProQR Therapeutics N.V. - Ordinary Shares
What is the ProQR Therapeutics N.V. - Ordinary Shares stock price today?
The current price of ProQR Therapeutics N.V. - Ordinary Shares (PRQR) is 1.7. Over the past 24 hours, the stock has changed by -1.73%. Follow the PRQR chart for real-time price dynamics.
What is the stock ticker of ProQR Therapeutics N.V. - Ordinary Shares?
ProQR Therapeutics N.V. - Ordinary Shares trades under the ticker PRQR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ProQR Therapeutics N.V. - Ordinary Shares stock going up?
PRQR has changed by +6.92% over the last week, +16.44% over the last month, and -31.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
How many employees does ProQR Therapeutics N.V. - Ordinary Shares have?
As of the latest available data, ProQR Therapeutics N.V. - Ordinary Shares has 187 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy ProQR Therapeutics N.V. - Ordinary Shares stock?
You can buy ProQR Therapeutics N.V. - Ordinary Shares (PRQR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ProQR Therapeutics N.V. - Ordinary Shares stock?
Investing in ProQR Therapeutics N.V. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRQR chart and related analysis on metatrader.com as part of your research.